Log In
BCIQ
Print this Print this
 

Cav3.2 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Cavion LLC
DescriptionCalcium channel voltage-dependent T type alpha 1H subunit (CACNA1H) (Cav3.2) inhibitor
Molecular Target Calcium channel voltage-dependent T type alpha 1H subunit (CACNA1H) (Cav3.2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat and prevent neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today